Remove tag epros
article thumbnail

Grand Rounds March 17, 2023: Remote Symptom Monitoring with Electronic Patient-Reported Outcomes (ePROs) in Oncology (Ethan Basch, MD, MSc)

Rethinking Clinical Trials

In this study adherence with week ePROs was 91.5%. – How do we take all of these ePRO options and choose something that is right for a trial? The intervention arm had to complete weekly PRO survey items from NCI PRO-CTCAE (pain, nausea, vomiting, constipation, diarrhea, dyspnea, insomnia, depression, oral intake).

article thumbnail

Life Sciences 2022 Year in Review

XTalks

The multi-million-dollar price tags are largely attributable to the high R&D and manufacturing costs associated with making a gene therapy, as the raw materials for producing the therapy can be expensive. Currently, CSL Behring’s one-dose Hemophilia B gene therapy Hemgenix holds the title at $3.5 million for a single infusion.